Comparison of tracer kinetic models for 68Ga-PSMA-11 PET in intermediate-risk primary prostate cancer patients
Abstract Background 68Ga-PSMA-11 positron emission tomography enables the detection of primary, recurrent, and metastatic prostate cancer. Regional radiopharmaceutical uptake is generally evaluated in static images and quantified as standard uptake values (SUVs) for clinical decision-making. However...
Main Authors: | Nathaniel J. Smith, Mark A. Green, Clinton D. Bahler, Mark Tann, Wendy Territo, Anne M. Smith, Gary D. Hutchins |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2024-01-01
|
Series: | EJNMMI Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13550-023-01066-2 |
Similar Items
-
Automated radiolabelling of [68Ga]Ga-PSMA-11 (gallium (68Ga)-gozetotide) using the Locametz® kit and two generators
by: Elke A. van Brandwijk, et al.
Published: (2024-04-01) -
Predicting the effect of different folate doses on [68Ga]Ga-PSMA-11 organ and tumor uptake using physiologically based pharmacokinetic modeling
by: Hinke Siebinga, et al.
Published: (2023-06-01) -
Otto: a 4.04 GBq (109 mCi) 68Ge/68Ga generator, first of its kind - extended quality control and performance evaluation in the clinical production of [68Ga]Ga-PSMA-11
by: Nicole N. Waterhouse, et al.
Published: (2020-02-01) -
Radiation dosimetry of [68Ga]PSMA-11 in low-risk prostate cancer patients
by: Kristina Sandgren, et al.
Published: (2019-01-01) -
Review and Suggestions for the Preparation and Quality Control of 68Ga-PSMA-11 Injection
by: YE Jiajun;ZHANG Mingru;WANG Jia;ZHU Zifan;KANG Fei;YANG Weidong;WANG Jing
Published: (2023-08-01)